Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.78 |
| ▸ | CA9 | Q16790 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21835011 | 0.89 | CA12 (0.80) | CA12CA9MAPTCYP2C9HSD17B10 | |
| SCHEMBL31344358 | 0.88 | CA12 (0.74) | CA12CA9MAPTCYP2C9HSD17B10 | |
| SCHEMBL6258750 | 0.88 | CA12 (0.74) | CA12CA9MAPTCYP2C9HSD17B10 | |
| SCHEMBL5063251 | 0.85 | CA12 (0.61) | CA12CA9MAPTCYP2C9HSD17B10 | |
| SCHEMBL30383399 | 0.81 | ALDH1A1 (0.71) | CA12CA9MAPTCYP2C9HSD17B10 | |
| Ethylene Glycol SCHEMBL28163407 | 0.80 | CA12 (0.52) | CA12CA9MAPTCYP2C9HSD17B10 | |
| SCHEMBL24864831 | 0.80 | CA12 (0.62) | CA12CA9MAPTCYP2C9HSD17B10 | |
| SCHEMBL831768 | 0.80 | CA12 (0.66) | CA12CA9MAPTCYP2C9HSD17B10 | |
| SCHEMBL29854772 | 0.80 | CA12 (0.66) | CA12CA9MAPTCYP2C9HSD17B10 | |
| SCHEMBL7753264 | 0.80 | CA12 (0.57) | CA12CA9MAPTCYP2C9HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9377466-B2 | Compounds and methods | MODPRO AB (SE) | 2016-06-28 | — | — | US | disclosed |
| US-20130261013-A1 | Compounds and Methods | MODPRO AB (SE) | 2013-10-03 | — | — | US | disclosed |
| EP-2613796-A2 | COMPOUNDS AND METHODS | Modpro AB (SE) | 2013-07-17 | — | — | EP | disclosed |
| WO-2012032068-A2 | COMPOUNDS AND METHODS | MODPRO AB (SE) | 2012-03-15 | — | — | WO | disclosed |
| EP-1590479-B1 | NUCLEIC ACID AMPLIFICATION | GE HEALTHCARE BIO SCIENCES (US) | 2010-11-24 | — | — | EP | disclosed |
| EP-1421213-B1 | LABELED NUCLEOSIDE POLYPHOSPHATES | GE HEALTHCARE BIO SCIENCES (US) | 2010-02-17 | — | — | EP | disclosed |
| US-7393640-B2 | Terminal-phosphate-labeled nucleotides with new linkers | GE HEALTHCARE BIO-SCIENCES CORP. (US) | 2008-07-01 | — | — | US | disclosed |
| US-7125671-B2 | Nucleic acid amplification with terminal-phosphate labeled nucleotides | GE HEALTHCARE BIO-SCIENCES CORP. (US) | 2006-10-24 | — | — | US | disclosed |
| US-7041812-B2 | Labeled nucleoside polyphosphates | AMERSHAM BIOSCIENCES CORP (US) | 2006-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130261013-A1 | Compounds and Methods | NOS2, NOS1, NOS3 | CA12 3108/4885CA9 3567/4885MAPT 2920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.